Pages that link to "Q30306363"
Jump to navigation
Jump to search
The following pages link to Ketamine controls prolonged status epilepticus (Q30306363):
Displaying 50 items.
- Pharmacotherapy for Status Epilepticus (Q26796689) (← links)
- Ketamine for the treatment of refractory status epilepticus (Q26799109) (← links)
- The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol (Q26997757) (← links)
- Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus (Q30308667) (← links)
- Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study (Q30411523) (← links)
- N-methyl-D-aspartic acid receptor activation downregulates expression of δ subunit-containing GABAA receptors in cultured hippocampal neurons (Q30412220) (← links)
- Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus (Q30412864) (← links)
- A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus (Q30433508) (← links)
- Status epilepticus increases the intracellular accumulation of GABAA receptors (Q30436046) (← links)
- A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation (Q30436689) (← links)
- Refractory and super-refractory status epilepticus--an update. (Q30807706) (← links)
- Prognostic factors of status epilepticus in children (Q33659264) (← links)
- Treatment of Convulsive and Nonconvulsive Status Epilepticus (Q34427751) (← links)
- Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations (Q34565141) (← links)
- Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466 (Q35950960) (← links)
- Status epilepticus: pathophysiology and management in adults (Q36400934) (← links)
- Literature review, case report, and expert discussion of prolonged refractory status epilepticus (Q36404830) (← links)
- Ketamine : from medicine to misuse (Q36418016) (← links)
- Treatment of acute seizures and status epilepticus (Q37019705) (← links)
- What is animal experimentation telling us about new drug treatments of status epilepticus? (Q37106031) (← links)
- (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study (Q37201609) (← links)
- Anesthetic management of a patient with Lennox-Gastaut syndrome with intractable epilepsy -a case report- (Q37292505) (← links)
- The electrocortical effects of enflurane: experiment and theory (Q37353960) (← links)
- Convulsive and nonconvulsive status epilepticus in children (Q37517969) (← links)
- Pharmacological management of seizures and status epilepticus in critically ill patients. (Q37867301) (← links)
- The NMDA receptor complex as a therapeutic target in epilepsy: a review (Q37953107) (← links)
- Management of acute seizure and status epilepticus in pediatric emergency (Q37961558) (← links)
- Treatment of status epilepticus with ketamine, are we there yet? (Q38100382) (← links)
- Levetiracetam use in the critical care setting (Q38132386) (← links)
- Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy (Q38646868) (← links)
- Pharmacologic treatment of status epilepticus (Q38656719) (← links)
- Status epilepticus in dogs and cats, part 2: treatment, monitoring, and prognosis (Q38818494) (← links)
- Severe refractory status epilepticus owing to presumed encephalitis (Q40510655) (← links)
- Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus (Q41318447) (← links)
- Status epilepticus: current treatment strategies (Q41860120) (← links)
- Super-Refractory Status Epilepticus: A Therapeutic Challenge in Paediatrics (Q41874312) (← links)
- Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus (Q42204171) (← links)
- Ketamine for medically refractory status epilepticus after elective aneurysm clipping. (Q42261813) (← links)
- Administration of lithium and magnesium chloride inhibited tolerance to the anticonvulsant effect of morphine on pentylenetetrazole-induced seizures in mice. (Q42870293) (← links)
- Voltage-dependent calcium channel and NMDA receptor antagonists augment anticonvulsant effects of lithium chloride on pentylenetetrazole-induced clonic seizures in mice (Q42982531) (← links)
- Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity (Q44332082) (← links)
- Effects of etomidate, ketamine or propofol, and their combinations with conventional antiepileptic drugs on amygdala-kindled convulsions in rats (Q44519051) (← links)
- Oral ketamine in paediatric non-convulsive status epilepticus (Q44580455) (← links)
- Interactions between non-barbiturate injectable anesthetics and conventional antiepileptic drugs in the maximal electroshock test in mice--an isobolographic analysis (Q44794350) (← links)
- Weak, physiologically patterned magnetic fields do not affect maze performance in normal rats, but disrupt seized rats normalized with ketamine: possible support for a neuromatrix concept? (Q44864553) (← links)
- Synergism between topiramate and budipine in refractory status epilepticus in the rat. (Q45127636) (← links)
- Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome (Q46819272) (← links)
- Flupirtine and diazepam combination terminates established status epilepticus: results in three rodent models (Q47149739) (← links)
- Practice variations in the management of status epilepticus. (Q47796407) (← links)
- Simultaneous triple therapy for the treatment of status epilepticus (Q47900531) (← links)